PERRANPORTH SURGERY
PERRANCOOMBE, PERRANPORTHCHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CHD 9 | 2005 | 243 | 260 | 93.5% | |
CHD 9 | 2006 | 256 | 260 | 98.5% | |
CHD 9 | 2007 | 271 | 274 | 98.9% | |
CHD 9 | 2008 | 273 | 291 | 93.8% | |
CHD 9 | 2009 | 265 | 283 | 93.6% | |
CHD 9 | 2010 | 270 | 289 | 93.4% | |
CHD 9 | 2011 | 277 | 299 | 92.6% | |
CHD 9 | 2012 | 273 | 294 | 92.9% | |
CHD 9 | 2013 | 279 | 298 | 93.6% | |
CHD005 | 2014 | 266 | 272 | 97.8% | |
CHD005 | 2015 | 269 | 277 | 97.1% | |
CHD005 | 2016 | 267 | 275 | 97.1% | |
CHD005 | 2017 | 260 | 267 | 97.4% | |
CHD005 | 2018 | 261 | 269 | 97.0% | |
CHD005 | 2019 | 268 | 278 | 96.4% | |
CHD005 | 2020 | 266 | 272 | 97.8% | |
CHD005 | 2021 | 262 | 283 | 92.6% | |
CHD005 | 2022 | 297 | 300 | 99.0% | |
CHD005 | 2023 | 291 | 301 | 96.7% |